Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01709383 · ClinicalTrials.gov registry record · NA
Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
A NA study of Aphasia, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 2
- Study locations
NCT01709383: Completed NA study of Aphasia, sponsored by Georgetown University.
NCT01709383 is a NA study of Aphasia that has completed, run by Georgetown University. The registered enrollment target is 38 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01709383, a NA study of Aphasia, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study tests whether weak electrical stimulation of the brain is effective in improving language or reading difficulties occurring after a brain injury or stroke.
Primary Outcome
This is a composite measure of verbal expression skills including tests of naming, verbal fluency, sentence completion, and responsive naming (one-word answers to basic questions). It is a subtest within the Western Aphasia Battery. The minimum score is 0 and maximum is 10, with 10 being the best outcome, and subscores are summed to determine the total score.
Conditions Studied
Interventions
- DEVICE Transcranial Direct Current Stimulation
- DEVICE Sham Stimulation
Study Locations (2)
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT01709383 record still lists
NCT01709383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Direct Current Stimulation is the first listed.
NCT01709383 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01709383 about?
NCT01709383 is a clinical study titled "Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia". This study tests whether weak electrical stimulation of the brain is effective in improving language or reading difficulties occurring after a brain injury or stroke.
What is the current status of trial NCT01709383?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2012-12. Estimated completion is 2015-09.
What conditions does trial NCT01709383 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT01709383?
The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE), Sham Stimulation (DEVICE).
Who is sponsoring clinical trial NCT01709383?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01709383 being conducted?
This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01709383's enrollment target sits among peer trials
38 32nd of 42 higher than 11 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia